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studies and health planning. Place is a subdiscipline 
of health geography.[7-9] This discipline addresses the 
spatial distribution of health outcome and geographical 
variations in diseases and their risk factors in the 
human population.[10,11] Epidemiologic studies have 
mainly placed greater emphasis on two elements of 
person and time rather than place. With developments 
in the geographic information system as a powerful, 
speedy tool, spatial paĴ erns could be investigated in 
epidemiologic studies and health management.[10-12] 
Identifying the paĴ erns of MI incidence, the paĴ erns 
of random, dispersed and cluster are important for 
management of MI.[12,13] Spatial analysis is frequently 
used for infectious diseases and cancer incidence.[13-15] 
This approach has been rarely used for cardiovascular 
diseases.[15] In Iran, no spatial analysis of MIs has been 
conducted to date. The present study was conducted to 
analyze MI spatially and determine the paĴ ern of MI 
geographical distribution in Iran by province.
INTRODUCTION
High prevalence and incidence of myocardial infarction 
(MI) as the most important cardiovascular disease 
and the reason for death has no geographical, spatial, 
gender, and social limit.[1,2] Mortality rate, per 100,000 
population, due to these diseases is 265 worldwide, 
224 in Eastern Mediterranean, and 171 in Iran.[2,3] By 
2020, cardiovascular disease-associated mortalities will 
increase by 15% in developed countries, 77% in China, 
and 106% in other Asian countries.[2,4] In epidemiologic 
studies, MI incidence rate in a population could be used 
as an index or alternative for estimation of coronary 
heart diseases and their burden.[5,6] Identifying and 
determining the paĴ ern of geographical distribution 
and spatial analysis of MIs contributes signifi cantly to 
implementing the plans and focusing on creative, novel 
initiatives in health system and mitigating disparity 
in cardiovascular diseases. Person, time, and place 
comprise three basic components in epidemiologic 
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MATERIALS AND METHODS
This study has two parts. One part is prospective and 
population-based, and the other part is an ecological study. 
In this study, the data of Iranian Myocardial Infarction 
Registry in all hospitals equipped with a Cardiac Care Unit 
in 31 provinces of Iran were used. Iran is one of the South-
Western Asian (Middle East) countries. It is bordered by 
Afghanistan and Pakistan from east, Turkmenistan from 
north-east, Caspian Sea from the middle north, Azerbaĳ an 
and Armenia from north-west, Turkey and Iraq from west, 
and Persian Gulf and Oman sea from south.[16] Inclusion 
criteria were based on World Health Organization (WHO) 
and World Heart Federation defi nition of MI diagnosis by 
International Classifi cation of Diseases (the codes I22, I21).[6] 
The patients with MI history or nondefi nite diagnosis made 
by the specialist were excluded from the study. The data on 
age, gender, and the province of residence were collected. 
Crude incidence rates were calculated for each province 
and whole country per 100,000 individuals based on sex. 
For the calculation of actual incidence rate in denominator, 
the data of population census by Statistical Center of Iran 
in 2011 were used. To adjust for age and gender eﬀ ects on 
geographical scales, direct standardization method and 
WHO standard population were used. For spatial analysis, 
global and local indicators of spatial autocorrelation, 
Moran’s I, and Getis-Ord were used. Moran’s I generally lies 
between +1 and −1. A Moran’s I of zero indicates the null 
hypothesis of no clustering, a positive Moran’s I indicates 
positive spatial autocorrelation (i.e., clustering of areas 
of similar aĴ ribute values), while a negative coeﬃ  cient 
indicates negative spatial autocorrelation (i.e., neighboring 
areas tend to have dissimilar aĴ ribute values). The Getis-
Ord is an indicator of local clustering that measures the 
concentration of a spatially distributed aĴ ribute variables. 
By comparing local estimates of spatial autocorrelation with 
global averages, the Getis-Ord identifi es hot spot in spatial 
data. The local Moran’s I detects local spatial autocorrelation 
in aggregated data by decomposing Moran’s I statistic into 
contributions for each area within a study region. These 
indicators detect clusters of either similar or dissimilar MI 
frequency values around a given observation.[17-19] To identify 
the factors associated with the spatial distribution of MI in 
ecological study (a binary response indicating the presence 
or absence of MI clustering at a given location), multiple 
logistic regression was used to model and simultaneously 
examine the variables’ eﬀ ect and to control confounding 
variables. The unit of analysis in the regression is a group 
of people, typically defi ned by geography. In ecological 
analysis of the study, MI risk factors (hypertension, diabetes, 
body mass index [BMI], smoking, diet, obesity, and blood 
lipid disorder) were used as group (prevalence rate) across 
the provinces. These factors were obtained from the national 
study of noncommunicable diseases (NCDs) risk factors 
in Iran and meteorological data (temperature, relative 
humidity, altitude, and precipitation) of the provinces from 
Iran Meteorological Organization. The methodology of the 
survey was based on WHO’s STEPwise approach to NCD 
surveillance. The methodology has been already described 
in other sources.[4,20,21] Data were analyzed by Stata SoĞ ware 
(Stata Corp. 2011. Stata Statistical SoĞ ware: Release 12. 
College Station, TX: Stata Corp LP) and ArcGIS (ESRI 2011. 
ArcGIS Desktop: Release 9.3).
RESULTS
Of 20,750 new cases of MI, 15,033 (72.4%) were male and 
the rest female. The mean age at MI development was 
by place significantly different among the provinces. 
Mean ± standard deviation of age was 59.6 ± 13.3 years in 
men, 65.4 ± 12.6 in women, and 61.2 ± 13.4 in the whole 
population. The mean age at MI incidence was signifi cantly 
diﬀ erent among the provinces.
Based on the coeﬃ  cient of global autocorrelation (spatial 
autocorrelation), a specifi c paĴ ern was observed in the 
distribution of MI incidence in diﬀ erent provinces (Moran’s 
Index: 0.751, variance: 0.017, Z-Score: 5.86 and P < 0.001).
Coeﬃ  cient of global autocorrelation per sex is shown in 
Table 1. Figure 1 depicts spatial paĴ ern of MI incidence 
by gender. MI incidence was clustering in six provinces 
(North Khorasan, Yazd, Kerman, Semnan, Golestan, 
and Mazandaran) Map A [Figure 1]. Spatial pattern 
of incidence was observed as clustering for men in six 
provinces (North Khorasan, Yazd, Kerman, Semnan, 
Quazvin, and Mazandaran) and for women in six provinces 
(North Khorasan, Yazd, Kerman, Semnan, Golestan, and 
Mazandaran) Maps B and C [Figure 1].
Table 2 indicates the results of spatial analysis and 
clusters. Figure 2 shows MI incidence hot spot in Golestan, 
Mazandaran, Quazvin, Zanjan, Yazd, North Khorasan, 
South Khorasan, Razavi Khorasan, Isfahan, Hamadan, and 
Semnan provinces Maps D, E, and F [Figure 2] show hot 
spot analysis for all, male, and female patients, respectively.
AĞ er entering diﬀ erent risk factors and meteorological factors 
in diﬀ erent logistic regression models, fi ve variables were 
Table 1: Coeffi cient of global autocorrelation for patterns 
of MI incidence in Iran in 2012
Statistic Total Male Female
Moran’s Index 0.751 0.748 0.74
Variance 0.017 0.017 0.017
Z 5.86 5.83 5.77
P 0.0001 0.0001 0.0001
MI = Myocardial infarction
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found as associated with clustered MI. Out of the associated 
factors with clustered MI in six provinces, temperature, 
humidity, hypertension, smoking, and BMI could be 
mentioned. Odds ratios (OR) of the associated factors with 
clustering are shown in Table 3. Hypertension, smoking, 
and BMI contributed to clustering with, respectively, 
2.36, 1.31, and 1.31 OR. The highest OR was obtained for 
hypertension, followed by BMI and smoking. Calculated ORs 
for the temperature and humidity were inversely correlated 
with mortality, MI: (0.97: 0.0.96-0.98) and (0.95: 0.93-0.97), 
respectively, OR = 95% confi dence interval.
DISCUSSION
The present work is the fi rst report on spatial analysis of 
MIs in Iran. Cardiovascular diseases are the fi rst reason for 
death in Iran and impose a large burden on community. 
Addressing the place-based paĴ ern of incidence and 
clarifying the epidemiologic dimension, including 
spatial analysis, has not yet been implemented in Iran. 
Therefore, the necessity of conducting this research is 
highly obvious to help decision makers and planners 
in the health system. Through these fi ndings, the plans 
concerning prevention and control of cardiovascular 
Figure 1: Cluster analysis: Z Score of Moran’s I for male, female and total patients with myocardial infarction in Iran; 2012
Table 2: Local autocorrelation for cluster detection and 
hot spot analysis (Getis-Ord) in six provinces in Iran
Cluster Province Local autocorrelation Getis-Ord
LMi Moran’s 
Index
LMi Z 
score
P LGi Z 
score
P
1 Golestan 3.47 2.11 0.035 2.78 0.005
2 North 
Khorasan
4.9 3.1 0.002 2.33 0.019
3 Kerman 4.64 2.23 0.025 1.88 0.059
4 Semnan 6.33 2.49 0.012 2.02 0.043
5 Yazd 4.9 2.59 0.009 2.13 0.032
6 Mazandaran 4.77 2.12 0.033 2.49 0.012
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diseases and MI, as the most important cause of death, 
could be desirably implemented.[22] Considering the 
limited resources and detecting the population at risk 
by place at provincial scale, prioritization in resource 
allocation and plans implementation in line with diﬀ erent 
levels of prevention (primary, secondary, tertiary) 
could be conducted more eﬃ  ciently. In this study, the 
hypothesis of random incidence of MI at national scale 
was examined by spatial analysis and global Moran’s I. 
This hypothesis was not confi rmed. Therefore, at global 
scale, MI incidence in Iran was observed as clustering. 
Then, this analysis was done at provincial scale, and 
MI incidence was found as clustering in six provinces. 
Spatial pattern of incidence was approximately the 
same in men and women. The results of our study are 
consistent with those of a study in Australia, reporting 
clustering incidence of MI.[15] By comparison, it is fully 
obvious that incidence rate of MI in Iran is higher than 
that in Japan.[23] This rate is higher in Spain and Finland 
compared to Iran. In Finland, incidence rate is the same in 
men and women, but spatial paĴ ern is various. Our study 
results are consistent with spatial diﬀ erence in incidence 
observed in the study of Finland.[24,25] In a study in the 
USA, the standardized incidence rate of MI in 20 states 
was reported 22.2-39.7/100,000 population of 35 years old 
and over in 2008. That study reported large geographical 
variations among the states. The comparison between 
our work with the study of US states indicates that the 
Figure 2: Hot spot analysis: Z Score of Getis-OrdGi* statistic (spatial statistics) for male, female and total patients with myocardial infarction in Iran; 2012
Table 3: OR in logistic regression model for infl uencing 
the presence clustering of MI in Iran; 2012
Explanatory variable OR 95% CI: OR P
Mean temperature 0.97 0.96-0.98 0.001
Relative humidity 0.95 0.93-0.97 0.001
Hypertension* 2.36 2.26-2.46 0.001
Smoking* 1.31 1.28-1.34 0.001
BMI 1.31 1.23-1.40 0.001
*Prevalence; CI = Confidence interval; OR = Odds ratio; BMI = Body mass index; 
MI = Myocardial infarction
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incidence rate in Iran’s provinces is variable similar to 
that in the US states, but incidence rate in Iran is higher 
compared to the USA.[26] Our fi ndings are in agreement 
with a study in Brazil in which out of 35 studied regions, 
31.4% of the regions had an MI incidence above national 
mean incidence and also MI incidence was unequal 
among diﬀ erent regions.[27]
Our fi ndings are consistent with those of the studies 
conducted in Canada, Australia, and Finland, reporting 
temperature, relative humidity, and hypertension as MI 
risk factors.[15,24,27,28] The diﬀ erence in MI incidence rate 
could be explained by various genetic, environmental 
factors or disparity of the disease risk factors in diﬀ erent 
provinces and socioeconomic classes. This issue requires 
further investigation in subsequent works. Although 
the quality of hospital registry of MI in Iran has been 
reported as acceptable,[29] failure to register MI cases 
who die outside hospital and no link between the MI and 
mortalities registry were of the limitations of this work 
and should be addressed in future research alongside 
periodical assessment of MIs registry to examine the 
precision of the registered cases until registry of data of 
MIs will become stable across Iran. Being population-
based, including all provinces of the country, and 
estimating the incidence based on formal, provincial 
borders and the population reported by Statistical Center 
of Iran per WHO standards, and defi nite diagnosis by 
the cardiologist could be considered as strengths of 
our work. In addition, this was the fi rst report on MI 
incidence in Iran. Ecological fallacy bias due to ecological 
analysis of the study and including grouped variables 
into analysis model are of limitations of this study, 
needing special interpretation. Ecological inferences will, 
therefore, continue to be made. Aggregate data are oĞ en 
easier to obtain than data on individuals, and may oﬀ er 
valuable clues to individual behavior.[30,31] The problems 
of confounding and aggregation bias, however, are 
unlikely to be resolved in near future. Deeper and more 
extensive studies should be conducted in six provinces of 
the country, where MI clustering was noted, to determine 
the reasons for clustering.
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